Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans

Cell(2024)10.1016/j.cell.2024.04.033Source: DataRank Database

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans is a research paper published in Cell (2024). On theSindex it has a DataRank of 0. It has been cited 50 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access50 citations

Download PDF

Cite:

Linked data & code

gen emdb nct pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 11.73)OA: hybridTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (5)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (48)

S. Munir Alam ORCID,Gilad Ofek ORCID,Nathaniel Erdmann,David C. Montefiori ORCID,Michael S. Seaman ORCID

Live enrichment

PubMed:38761800 PMC:PMC11993910 OpenAlex:https://openalex.org/W4397002620

NIAID NIH HHS

Grant: UM1 AI144371

Gates Foundation

Grant: INV-007688

NIAID NIH HHS

Grant: R37 AI150590

NIAID NIH HHS

Grant: U54 AI170752

NIAID NIH HHS

Grant: UM1 AI100645

Bill and Melinda Gates Foundation

National Institute of Allergy and Infectious Diseases

National Institutes of Health

U.S. Department of Health and Human Services

FWCI

11.73

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttp://www.cell.com/article/S0092867424004598/pdf

publisherhttp://www.cell.com/article/S0092867424004598/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867424004598?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867424004598?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cell.2024.04.033

Fields of Study

HIV Research and Treatmentvaccines and immunoinformatics approachesImmune Cell Function and Interaction

MeSH Terms

B-LymphocytesHumansLiposomesMutationHIV AntibodiesHIV-1HIV InfectionsHIV Envelope Protein gp41AIDS VaccinesCell Lineageenv Gene Products, Human Immunodeficiency VirusAntibodies, Neutralizing

Keywords

BiologyImmunogenVirologyHeterologousGp41AntibodyPolyclonal antibodiesNeutralizing antibodyNeutralizationHIV vaccineLineage (genetic)B cellVirusGeneMonoclonal antibodyHuman immunodeficiency virus (HIV)EpitopeImmunologyGeneticsVaccine trial

Sustainable Development Goals

SDG 0: Good health and well-being

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans

FAIR Checklist

Authors (48)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)